China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 6.66 billion. The enterprise value is 4.96 billion.
| Market Cap | 6.66B |
| Enterprise Value | 4.96B |
Important Dates
The next estimated earnings date is Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Jul 8, 2025 |
Share Statistics
SHE:301333 has 95.14 million shares outstanding. The number of shares has increased by 21.90% in one year.
| Current Share Class | 95.14M |
| Shares Outstanding | 95.14M |
| Shares Change (YoY) | +21.90% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 12.43% |
| Owned by Institutions (%) | 12.92% |
| Float | 30.59M |
Valuation Ratios
The trailing PE ratio is 43.99 and the forward PE ratio is 44.73.
| PE Ratio | 43.99 |
| Forward PE | 44.73 |
| PS Ratio | 8.44 |
| PB Ratio | 3.46 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | 111.45 |
| P/OCF Ratio | 79.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.02, with an EV/FCF ratio of 82.91.
| EV / Earnings | 32.74 |
| EV / Sales | 6.28 |
| EV / EBITDA | 34.02 |
| EV / EBIT | 36.42 |
| EV / FCF | 82.91 |
Financial Position
The company has a current ratio of 5.96, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.96 |
| Quick Ratio | 5.72 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.15 |
| Interest Coverage | 44.09 |
Financial Efficiency
Return on equity (ROE) is 8.22% and return on invested capital (ROIC) is 60.57%.
| Return on Equity (ROE) | 8.22% |
| Return on Assets (ROA) | 3.68% |
| Return on Invested Capital (ROIC) | 60.57% |
| Return on Capital Employed (ROCE) | 6.92% |
| Revenue Per Employee | 357,541 |
| Profits Per Employee | 68,556 |
| Employee Count | 2,208 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 7.33 |
Taxes
In the past 12 months, SHE:301333 has paid 17.67 million in taxes.
| Income Tax | 17.67M |
| Effective Tax Rate | 10.37% |
Stock Price Statistics
The stock price has increased by +48.39% in the last 52 weeks. The beta is 0.58, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +48.39% |
| 50-Day Moving Average | 61.06 |
| 200-Day Moving Average | 54.24 |
| Relative Strength Index (RSI) | 54.93 |
| Average Volume (20 Days) | 3,418,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 789.45 million and earned 151.37 million in profits. Earnings per share was 1.59.
| Revenue | 789.45M |
| Gross Profit | 271.98M |
| Operating Income | 136.07M |
| Pretax Income | 170.40M |
| Net Income | 151.37M |
| EBITDA | 132.68M |
| EBIT | 136.07M |
| Earnings Per Share (EPS) | 1.59 |
Balance Sheet
The company has 1.72 billion in cash and 9.23 million in debt, with a net cash position of 1.71 billion or 17.98 per share.
| Cash & Cash Equivalents | 1.72B |
| Total Debt | 9.23M |
| Net Cash | 1.71B |
| Net Cash Per Share | 17.98 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 20.19 |
| Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was 83.79 million and capital expenditures -24.03 million, giving a free cash flow of 59.76 million.
| Operating Cash Flow | 83.79M |
| Capital Expenditures | -24.03M |
| Free Cash Flow | 59.76M |
| FCF Per Share | 0.63 |
Margins
Gross margin is 34.45%, with operating and profit margins of 17.24% and 19.17%.
| Gross Margin | 34.45% |
| Operating Margin | 17.24% |
| Pretax Margin | 21.58% |
| Profit Margin | 19.17% |
| EBITDA Margin | 16.81% |
| EBIT Margin | 17.24% |
| FCF Margin | 7.57% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 10.37% |
| Buyback Yield | -21.90% |
| Shareholder Yield | -21.67% |
| Earnings Yield | 2.27% |
| FCF Yield | 0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301333 has an Altman Z-Score of 9.54 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.54 |
| Piotroski F-Score | 4 |